CYTOSIMILARS
LIVE

Serial Number

79338308

Owner

Cytosimilars GmbH

Attorney

Brian P. Sullivan

Filing Date

Dec 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CYTOSIMILARS Trademark

Serial Number: 79338308 • Registration: 7171798

CYTOSIMILARS is a trademark filed by Cytosimilars GmbH on December 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cytosimilars GmbH

Bernstorffstraße 117

Entity Type: 28

Trademark Details

Filing Date

December 13, 2021

Registration Date

September 26, 2023

Published for Opposition

July 11, 2023

Goods & Services

Alternative medicine services; health counselling; medical analysis services relating to the treatment of persons; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of samples of human cells taken from patients; medical laboratory services for the analysis of samples of stem cells taken from patients; medical diagnostic services

Medicines, pharmaceutical preparations and biological preparations for human and veterinary purposes, namely, for use in connection with stem cell differentiations, stem cell therapies, cancer treatments, autoimmune disease treatments and allergy treatments for humans and animals

Biological research and analysis; Research and development of new products for others; Research and development of new products for use in stem cell differentiation for others; Medical and scientific research, namely, conducting clinical trials for others; Scientific research for medical purposes in the field of stem cell differentiation; Scientific research for medical purpose relating to stem cell differentiation; Pharmaceutical research and development; Research in the field of medicine; Research in the field of medicine in the area of stem cell differentiation; Research on the subject of pharmaceuticals; Scientific research in the field of pharmacy; Research and development in the pharmaceutical and biotechnology fields; Consultancy relating to pharmaceutical research and development; Consultancy relating to research and development in the field of therapeutics; Provision of information and data relating to medical and veterinary research and development; Provision of information and data relating to medical and veterinary research and development in the field of stem cell differentiation; Scientific laboratory services for analytical testing; Medical laboratory services for analytical testing relating to stem cell differentiation; Medical research laboratory services; Medical research laboratory services in the field of stem cell differentiation

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 22, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 3, 2024 FICS
FINAL DISPOSITION PROCESSED
Jan 3, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 26, 2023 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 9, 2023 OPNX
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 26, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 26, 2023 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 20, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 20, 2023 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2023 PUBO
NOTIFICATION PROCESSED BY IB
Jul 10, 2023 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 21, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 21, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 5, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 5, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 5, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 5, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 2, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 16, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 28, 2023 COAR
REFUSAL PROCESSED BY IB
Jan 15, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 27, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 27, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 6, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 5, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 19, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 15, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 14, 2022 REPR